研究奨励賞

第24回（2024年）

寺西 立冴

Teranishi R, Takahashi T, Nishida T, Kurokawa Y, Nakajima K, Koh M, et al. Plasma trough concentration of imatinib and its effect on therapeutic efficacy and adverse events in Japanese patients with GIST. Int J Clin Oncol. 2023 May;28(5):680–7.

稲山 嘉英

Inayama Y, Mizuno K, Yamaguchi K, Hamanishi J, Takeuchi M, Egawa M, et al. Real-world practice of estrogen therapy after surgery for endometrial cancer: a descriptive study using a Japanese claims database. Int J Clin Oncol. 2023 Mar;28(3):445–53.

佐藤 方宣

Sato M, Enokida T, Wada A, Okano S, Tanaka H, Fujisawa T, et al. Potential efficacy of local therapy for progressive lesions after nivolumab in patients with recurrent or metastatic squamous cell carcinoma of the head and neck. Int J Clin Oncol. 2023 Aug;28(8):1023–32.

第23回（2023年）

近藤 知大

Kondo T, Yamamoto Y, Fukuyama K, Kanai M, Yamada A, Matsubara J, et al. Germline sequencing for presumed germline pathogenic variants via tumor-only comprehensive genomic profiling. Int J Clin Oncol. 2022 Aug;27(8):1256-63.

冨田 諒太郎

Tomida R, Miyake M, Minato R, Sawada Y, Matsumura M, Iida K, et al. Impact of carcinoma in situ on the outcome of intravesical Bacillus Calmette-Guérin therapy for non-muscle-invasive bladder cancer: a comparative analysis of large real-world data. Int J Clin Oncol. 2022 May;27(5):958-68.

土肥 洋一郎

Tohi Y, Kato T, Nakamura M, Matsumoto R, Sasaki H, Mitsuzuka K, et al. Deferred radical prostatectomy in patients who initially elected for active surveillance: a multi-institutional, prospective, observational cohort of the PRIAS-JAPAN study. Int J Clin Oncol. 2022 Jan;27(1):194-201.

第22回（2022年）

城戸 宏一

Kido K, Hatakeyama S, Numakura K, Tanaka T, Oikawa M, Noro D, et al. Comparison of nivolumab plus ipilimumab with tyrosine kinase inhibitors as first-line therapies for metastatic renal-cell carcinoma: a multicenter retrospective study. Int J Clin Oncol. 2021Jan;26(1):154-62.

高雄 美里

Takao M, Yamaguchi T, Eguchi H, Yamada T, Okazaki Y, Tomita N, et al. APC germline variant analysis in the adenomatous polyposis phenotype in Japanese patients. Int J Clin Oncol. 2021 Sep;26(9):1661-70.

加藤 泰裕

Kato Y, Yamamoto G, Watanabe Y, Yamane Y, Mizutani H, Kurimoto F, et al. Long-term efficacy of immune checkpoint inhibitors in non-small cell lung cancer patients harboring MET exon 14 skipping mutations. Int J Clin Oncol. 2021 Jun;26(6):1065-72.

第21回（2021年）

田口 大樹

Taguchi D, Inoue M, Fukuda K, Yoshida T, Shimazu K, Fujita K, et al. Therapeutic drug monitoring of regorafenib and its metabolite M5 can predict treatment efficacy and the occurrence of skin toxicities. Int J Clin Oncol. 2020 Apr;25(4):531-40.

三宅 牧人

Miyake M, Matsuyama H, Teramukai S, Kinoshita F, Yokota I, Matsumoto H, et al. A new risk stratification model for intravesical recurrence, disease progression, and cancer-specific death in patients with non-muscle invasive bladder cancer: the J-NICE risk tables. Int J Clin Oncol. 2020 Jul;25(7):1364-76.

小林 実

Kobayashi M, Sato R, Komura T, Ichikawa H, Hirashima T, Otake S, et al. Protective effect of the oral administration of cystine and theanine on oxaliplatin-induced peripheral neuropathy: a pilot randomized trial. Int J Clin Oncol. 2020 Oct;25(10):1814-21.

第20回（2020年）

小林 良幸

Kobayashi Y, Tabata T, Omori M, Kondo E, Hirata T, Yoshida K, et al. A Japanese survey of malignant disease in pregnancy. Int J Clin Oncol. 2019 Mar;24(3):328-33.

相澤 理人

Aizawa R, Takayama K, Nakamura K, Inoue T, Yamasaki T, Kobayashi T, et al. Ten-year outcomes of high-dose intensity-modulated radiation therapy for nonmetastatic prostate cancer with unfavorable risk: early initiation of salvage therapy may replace long-term adjuvant androgen deprivation. Int J Clin Oncol. 2019 Oct;24(10):1247-55.

橋本 淳

Hashimoto J, Kato K, Ito Y, Kojima T, Akimoto T, Daiko H, et al. Phase II feasibility study of preoperative concurrent chemoradiotherapy with cisplatin plus 5-fluorouracil and elective lymph node irradiation for clinical stage II/III esophageal squamous cell carcinoma. Int J Clin Oncol. 2019 Jan;24(1):60-7.

第19回（2019年）

塚田 庸一郎

Tsukada Y, Higashi T, Shimada H, Kikuchi Y, Terahara A. The use of neoadjuvant therapy for resectable locally advanced thoracic esophageal squamous cell carcinoma in an analysis of 5016 patients from 305 designated cancer care hospitals in Japan. Int J Clin Oncol. 2018 Feb;23(1):81-91.

森實 修一

Morizane S, Honda M, Fukasawa S, Komaru A, Inokuchi J, Eto M, et al. Comparison of the diagnostic efficacy and perioperative outcomes of limited versus extended pelvic lymphadenectomy during robot-assisted radical prostatectomy: a multi-institutional retrospective study in Japan. Int J Clin Oncol. 2018 Jun;23(3):568-75.

中村 清直

Nakamura K, Mizowaki T, Inokuchi H, Ikeda I, Inoue T, Kamba T, et al. Decreased acute toxicities of intensity-modulated radiation therapy for localized prostate cancer with prostate-based versus bone-based image guidance. Int J Clin Oncol. 2018 Feb;23(1):158-64.

第18回（2018年）

岡村 亮輔

Okamura R, Hasegawa S, Hida K, Hoshino N, Kawada K, Sugihara K, et al. The role of periodic serum CA19-9 test in surveillance after colorectal cancer surgery. Int J Clin Oncol. 2017 Feb;22(1):96-101.

杉谷 郁子

Sugitani I, Ueda S, Sakurai T, Shigekawa T, Hirokawa E, Shimada H, et al. Neoadjuvant chemotherapy with trastuzumab, docetaxel, and carboplatin administered every 3 weeks for Japanese women with HER2-positive primary breast cancer: efficacy and safety. Int J Clin Oncol. 2017 Oct;22(5):880-6.

安藤 幸滋

Ando K, Emi Y, Suenaga T, Hamanoue M, Maekawa S, Sakamoto Y, et al. A prospective study of XELIRI plus bevacizumab as a first-line therapy in Japanese patients with unresectable or recurrent colorectal cancer (KSCC1101). Int J Clin Oncol. 2017 Oct;22(5):913-20.

第17回（2017年）

永原 啓

Nagahara A, Uemura M, Kawashima A, Ujike T, Fujita K, Miyagawa Y, et al. R.E.N.A.L. nephrometry score predicts postoperative recurrence of localized renal cell carcinoma treated by radical nephrectomy. Int J Clin Oncol. 2016 Apr;21(2):367-72.

波戸 ゆかり

Hato Y, Kondo N, Yoshimoto N, Endo Y, Asano T, Dong Y, et al. Prognostic impact of a single-nucleotide polymorphism near the CTSO gene in hormone receptor-positive breast cancer patients. Int J Clin Oncol. 2016 Jun;21(3):539-47.

慎 武

Shin T, Kobayashi T, Shimomura Y, Iwahata T, Suzuki K, Tanaka T, et al. Microdissection testicular sperm extraction in Japanese patients with persistent azoospermia after chemotherapy. Int J Clin Oncol. 2016 Dec;21(6):1167-71.

第16回（2016年）

中村 優子

Nakamura Y, Matsumoto K, Satoh T, Nishide K, Nozue A, Shimabukuro K, et al. Optimizing biopsy procedures during colposcopy for women with abnormal cervical cancer screening results: a multicenter prospective study. Int J Clin Oncol. 2015 Jun;20(3):579-85.

井上 正広

Inoue M, Takahashi S, Soeda H, Shimodaira H, Watanabe M, Miura K, et al. Gene-expression profiles correlate with the efficacy of anti-EGFR therapy and chemotherapy for colorectal cancer. Int J Clin Oncol. 2015 Dec;20(6):1147-55.

第15回（2015年）

竹内 英樹

Takeuchi H, Takei H, Futsuhara K, Yoshida T, Kojima M, Kai T, et al. A multicenter prospective study to evaluate bone fracture related to adjuvant anastrozole in Japanese postmenopausal women with breast cancer: two-year interim analysis of Saitama Breast Cancer Clinical Study Group (SBCCSG-06). Int J Clin Oncol. 2014 Feb;19(1):68-73.

金子 由香

Kaneko Y, Kuramochi H, Nakajima G, Inoue Y, Yamamoto M. Degraded DNA may induce discordance of KRAS status between primary colorectal cancer and corresponding liver metastases. Int J Clin Oncol. 2014 Feb;19(1):113-20.

緒方 大

Ogata D, Uematsu T, Yoshikawa S, Kiyohara Y. Accuracy of real-time ultrasound elastography in the differential diagnosis of lymph nodes in cutaneous malignant melanoma (CMM): a pilot study. Int J Clin Oncol. 2014 Aug;19(4):716-21.

第14回（2014年）

全田 貞幹

Zenda S, Ishi S, Kawashima M, Arahira S, Tahara M, Hayashi R, et al. A Dermatitis Control Program (DeCoP) for head and neck cancer patients receiving radiotherapy: a prospective phase II study. Int J Clin Oncol. 2013 Apr;18(2):350-5.

馬場 哲郎

Baba T, Shiota H, Kuroda K, Shigematsu Y, Ichiki Y, Uramoto H, et al. Clinical significance of human leukocyte antigen loss and melanoma-associated antigen 4 expression in smokers of non-small cell lung cancer patients. Int J Clin Oncol. 2013 Dec;18(6):997-1004.

第13回（2013年）

成田 伸太郎

Narita S, Tsuchiya N, Yuasa T, Maita S, Obara T, Numakura K, et al. Outcome, clinical prognostic factors and genetic predictors of adverse reactions of intermittent combination chemotherapy with docetaxel, estramustine phosphate and carboplatin for castration-resistant prostate cancer. Int J Clin Oncol. 2012 Jun;17(3):204-11.

林 直輝

Hayashi N, Nakamura S, Tokuda Y, Shimoda Y, Yagata H, Yoshida A, et al. Prognostic value of HER2-positive circulating tumor cells in patients with metastatic breast cancer. Int J Clin Oncol. 2012 Apr;17(2):96-104.

第12回（2012年）

葛西 和博

Kasai K, Ushio A, Kasai Y, Sawara K, Miyamoto Y, Oikawa K, et al. Combination therapy of intra-arterial 5-fluorouracil and systemic pegylated interferon α-2b for advanced hepatocellular carcinoma. Int J Clin Oncol. 2011 Jun;16(3):221-9.

若槻 尊

Wakatsuki T, Irisawa A, Terashima M, Shibukawa G, Takagi T, Imamura H, et al. ATP assay-guided chemosensitivity testing for gemcitabine with biopsy specimens obtained from unresectable pancreatic cancer using endoscopic ultrasonography-guided fine-needle aspiration. Int J Clin Oncol. 2011 Aug;16(4):387-94.

第11回（2011年）

小川 伸二

Ogawa S, Kobayashi H, Amada S, Yahata H, Sonoda K, Abe K, et al. Sentinel node detection with (99m)Tc phytate alone is satisfactory for cervical cancer patients undergoing radical hysterectomy and pelvic lymphadenectomy. Int J Clin Oncol. 2010 Feb;15(1):52-8.

園田 順彦

Sonoda Y, Yokosawa M, Saito R, Kanamori M, Yamashita Y, Kumabe T, et al. O(6)-Methylguanine DNA methyltransferase determined by promoter hypermethylation and immunohistochemical expression is correlated with progression-free survival in patients with glioblastoma. Int J Clin Oncol. 2010 Aug;15(4):352-8.

第10回（2010年）

林 宏一

Hayashi K, Koga H, Uhara H, Saida T. High-frequency 30-MHz sonography in preoperative assessment of tumor thickness of primary melanoma: usefulness in determination of surgical margin and indication for sentinel lymph node biopsy. Int J Clin Oncol. 2009 Oct;14(5):426-30.

第9回（2009年）

米村 豊

Yonemura Y, Wu CC, Fukushima N, Honda I, Bandou E, Kawamura T, et al. Randomized clinical trial of D2 and extended paraaortic lymphadenectomy in patients with gastric cancer. Int J Clin Oncol. 2008 Apr;13(2):132-7.

西田 俊朗

Nishida T, Shirao K, Sawaki A, Koseki M, Okamura T, Ohtsu A, et al. Efficacy and safety profile of imatinib mesylate (ST1571) in Japanese patients with advanced gastrointestinal stromal tumors: a phase II study (STI571B1202). Int J Clin Oncol. 2008 Jun;13(3):244-51.

木南 伸一

Kinami S, Fujimura T, Ojima E, Fushida S, Ojima T, Funaki H, et al. PTD classification: proposal for a new classification of gastric cancer location based on physiological lymphatic flow. Int J Clin Oncol. 2008 Aug;13(4):320-9.

第8回（2008年）

高橋 剛

Takahashi T, Nakajima K, Nishitani A, Souma Y, Hirota S, Sawa Y, et al. An enhanced risk-group stratification system for more practical prognostication of clinically malignant gastrointestinal stromal tumors. Int J Clin Oncol. 2007 Oct;12(5):369-74.

細井 創

Hosoi H, Teramukai S, Matsumoto Y, Tsuchiya K, Iehara T, Hara J, et al. A review of 331 rhabdomyosarcoma cases in patients treated between 1991 and 2002 in Japan. Int J Clin Oncol. 2007 Apr;12(2):137-45.

光森 通英

Mitsumori M, Zeng ZF, Oliynychenko P, Park JH, Choi IB, Tatsuzaki H, et al. Regional hyperthermia combined with radiotherapy for locally advanced non-small cell lung cancers: a multi-institutional prospective randomized trial of the International Atomic Energy Agency. Int J Clin Oncol. 2007 Jun;12(3):192-8.

第7回（2007年）

石原 剛

Ishihara T, Kaguchi A, Matsushita S, Shiraishi S, Tomiguchi S, Yamashita Y, et al. Management of sentinel lymph nodes in malignant skin tumors using dynamic lymphoscintigraphy and the single-photon-emission computed tomography/computed tomography combined system. Int J Clin Oncol. 2006 Jun;11(3):214-20.

岩間 毅夫

Iwama T, Akasu T, Utsunomiya J, Muto T. Does a selective cyclooxygenase-2 inhibitor (tiracoxib) induce clinically sufficient suppression of adenomas in patients with familial adenomatous polyposis?
A randomized double-blind placebo-controlled clinical trial. Int J Clin Oncol. 2006 Apr;11(2):133-9.

川上 理

Kawakami S, Hyochi N, Yonese J, Yano M, Fujii Y, Kageyama Y, et al. Three-dimensional combination of transrectal and transperineal biopsies for efficient detection of stage T1c prostate cancer. Int J Clin Oncol. 2006 Apr;11(2):127-32.

第6回（2006年）

大橋 俊夫

Ohashi T, Yorozu A, Toya K, Saito S, Momma T. Acute urinary morbidity following I-125 prostate brachytherapy. Int J Clin Oncol. 2005 Aug;10(4):262-8.

佐藤 康裕

Sato Y, Kondo H, Honda K, Takahari D, Sumiyoshi T, Tsuji Y, et al. A phase I/II study of S-1 plus cisplatin in patients with advanced gastric cancer: 2-week S-1 administration regimen. Int J Clin Oncol. 2005 Feb;10(1):40-4.

松井 喜之

Matsui Y, Nishiyama H, Watanabe J, Teramukai S, Ono Y, Ohshima S, et al. The current status of perioperative chemotherapy for invasive bladder cancer: a multiinstitutional retrospective study in Japan. Int J Clin Oncol. 2005 Apr;10(2):133-8.

第5回（2005年）

荒井 渉

Arai W, Hosoya Y, Hyodo M, Yokoyama T, Hirashima Y, Yasuda Y, et al. Alternate-day oral therapy with TS-1 for advanced gastric cancer. Int J Clin Oncol. 2004 Jun;9(3):143-8.

藤井 正人

Fujii M, Tsukuda M, Satake B, Kubota A, Kida A, Kohno N, et al. Phase I/II trial of weekly docetaxel and concomitant radiotherapy for squamous cell carcinoma of the head and neck. Int J Clin Oncol. 2004 Apr;9(2):107-12.

黎 功

Li G, Mitsumori M, Ogura M, Horii N, Kawamura S, Masunaga S, et al. Local hyperthermia combined with external irradiation for regional recurrent breast carcinoma. Int J Clin Oncol. 2004 Jun;9(3):179-83.

第4回（2004年）

Lucy Sayuri Ito

Ito LS, Oba-Shinjo SM, Marie SK, Uno M, Shinjo SK, Hamajima N, et al. Lifestyle factors associated with atrophic gastritis among Helicobacter pylori-seropositive Japanese-Brazilians in São Paulo. Int J Clin Oncol. 2003 Dec;8(6):362-8.

岩瀬 弘明

Iwase H, Shimada M, Nakamura M, Nakarai K, Iyo T, Kaida S, et al. Concurrent chemoradiotherapy for locally advanced and metastatic esophageal cancer: longterm results of a phase II study of UFT/CDDP with radiotherapy. Int J Clin Oncol. 2003 Oct;8(5):305-11.

第3回（2003年）

大野 毅

Ohno T, Kawano K, Sasaki A, Aramaki M, Tahara K, Etoh T, et al. Antitumor and antivascular effects of AC-7700, a combretastatin A-4 derivative, against rat liver cancer. Int J Clin Oncol. 2002 Jun;7(3):171-6.

浜島 信之

Hamajima N, Matsuo K, Iwata H, Shinoda M, Yamamura Y, Kato T, et al. NAD(P)H: quinone oxidoreductase 1 (NQO1) C609T polymorphism and the risk of eight cancers for Japanese. Int J Clin Oncol. 2002 Apr;7(2):103-8.

松本 誠一

Matsumoto S, Kawaguchi N, Manabe J, Matsushita Y. "In situ preparation": new surgical procedure indicated for soft-tissue sarcoma of a lower limb in close proximity to major neurovascular structures. Int J Clin Oncol. 2002 Feb;7(1):51-6.

第2回（2002年）

青山 法夫

Aoyama N, Koizumi H, Minamide J, Yoneyama K, Isono K. Prognosis of patients with advanced carcinoma of the esophagus with complete response to chemotherapy and/or radiation therapy: a questionnaire survey in Japan. Int J Clin Oncol. 2001 Jun;6(3):132-7.

原田 嘉和

Harada Y, Ogata Y, Shirouzu K. Expression of vascular endothelial growth factor and its receptor KDR (kinase domain-containing receptor)/Flk-1 (fetal liver kinase-1) as prognostic factors in human colorectal cancer. Int J Clin Oncol. 2001 Oct;6(5):221-8.

李 柱南

Li Z, Takeuchi S, Otani T, Maruo T. Implications of adrenomedullin expression in the invasion of squamous cell carcinoma of the uterine cervix. Int J Clin Oncol. 2001 Dec;6(6):263-70.

第1回（2001年）

辛 栄成

Shin E, Takatsuka Y, Nishisho I, Fujitani K, Mishima H, Sawamura T, et al. Prognostic significance of c-erb B-2 protein status using an enzyme immunoassay in breast cancer. Int J Clin Oncol. 2000 Feb;5(1):12-7.

Hirammoy Das

Das H, Koizumi T, Sugimoto T, Yamaguchi S, Hasegawa K, Tenjin Y, et al. Induction of apoptosis and manganese superoxide dismutase gene by photodynamic therapy in cervical carcinoma cell lines. International Journal of Clinical Oncology. 2000 Apr;5(2):97-103.

古谷 雄三

Furuya Y, Akakura K, Ito H. Value of free-to-total prostate-specific antigen ratio for detection and staging of prostate cancer. Int J Clin Oncol. 2000 Feb;5(1):8-11.